The latest news & stories from the Providence Research Network

  • How healthcare experiences impact preventative mammography: An interview with CORE's Monique Gill

    How healthcare experiences impact preventative mammography: An interview with CORE's Monique Gill

    In a new interview, Providence CORE researcher Monique Gill discusses CORE’s research on the links between healthcare experiences and engagement with mammography.

    Read Article
  • Bringing world-class procedures to remote patients

    Bringing world-class procedures to remote patients

    Learn how Providence is bringing top-tier research to its rural health programs so patients have access to lifesaving therapies – wherever they are.

    Read Article
  • Immunotherapies for GI and lung cancers evaluated in new studies

    Immunotherapies for GI and lung cancers evaluated in new studies

    A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

    Read Article
  • Genomic testing can improve outcomes for people with advanced cancer, study shows

    Genomic testing can improve outcomes for people with advanced cancer, study shows

    Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

    Read Article
  • Providence researchers contribute to 21 studies at SITC2023

    Providence researchers contribute to 21 studies at SITC2023

    SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

    Read Article
  • Understanding long COVID based on patient experiences

    Understanding long COVID based on patient experiences

    A new study examined patient experiences with long-COVID and identified four distinct groupings encompassing the wide-ranging experiences of long COVID patients.

    Read Article
  • Wish you could get rid of your COVID-19 symptoms sooner? Be part of a new study

    Wish you could get rid of your COVID-19 symptoms sooner? Be part of a new study

    The OakTree study is looking at a new COVID-19 drug to see if it can shorten the time you have symptoms. Learn more about participating.

    Read Article
  •  Dr. Kelly Paulson wins first Jeff Ward Award

    Dr. Kelly Paulson wins first Jeff Ward Award

    Swedish Edmonds Dr. Kelly Paulson wins the first-ever Jeff Ward Award for excellence in care.

    Read Article
  • The Search for New and Better Answers

    The Search for New and Better Answers

    Jaundice was the first symptom of what a CT scan would confirm was pancreatic cancer. A small tumor blocked one of Sharon Stefan’s bile ducts, causing the telltale symptom that, for many, doesn’t appe

    Read Article
  • Drawing on patient experiences, Providence study identifies four categories of long COVID and reveals importance of whole-person care

    Drawing on patient experiences, Providence study identifies four categories of long COVID and reveals importance of whole-person care

    Providence study seeks to help practitioners better identify and care for patients by providing a more comprehensive understanding of how long COVID presents and the patient experience of this disease

    Read Article
  • New studies address unmet needs in treating triple-negative breast cancer

    New studies address unmet needs in treating triple-negative breast cancer

    Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

    Read Article
  • A recent study found rising cancer rates among younger adults. What to know.

    A recent study found rising cancer rates among younger adults. What to know.

    A recent study found an increased prevalence of cancer in people under 50. The study noted increases of endocrine, gastrointestinal and breast cancers in people between the ages of 30 and 39.

    Read Article
  • Dr. Urba receives award for his contributions to science and community

    Dr. Urba receives award for his contributions to science and community

    Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.

    Read Article
  • An antidote for addiction? Providence tests new meth treatment.

    An antidote for addiction? Providence tests new meth treatment.

    The METH-OD Study works to reverse the effects of Methamphetamine abuse. Read more about this innovative research and its successful outcomes for patients.

    Read Article
  • We’re winning the fight against prostate cancer

    We’re winning the fight against prostate cancer

    Providence Swedish is at the forefront of new technologies that decrease pain and shorten recovery time for prostate cancer patients.

    Read Article
  • New division director and deputy director of Hematology and Medical Oncology share a vision

    New division director and deputy director of Hematology and Medical Oncology share a vision

    Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

    Read Article
  • New study aims to fill treatment gap for patients with endometrial cancer

    New study aims to fill treatment gap for patients with endometrial cancer

    For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

    Read Article
  • A promising breakthrough in Leukemia treatments

    A promising breakthrough in Leukemia treatments

    A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma

    Read Article
  • CORE study links a value-based payment model with increased outpatient healthcare use

    CORE study links a value-based payment model with increased outpatient healthcare use

    A new study by Providence CORE linked a Value-based Payment Model with increased use of primary and specialty care among patients. Findings also highlight the importance of clinical staff buy-in.

    Read Article
  • Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

    Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas

    New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

    Read Article
  • loading
    Loading More...